Skip to content
Partnerships
News
Contact
Fore Biotherapeutics
Pipeline
Science
Plixorafenib Program
Publications
Patients
Our Science Explained
Clinical Trials
Forte Trial
Expanded Access
Company
About Us
People
Leadership
Investors
Careers
Governance
Search
Pipeline
Science
Plixorafenib Program
Publications
Patients
Our Science Explained
Clinical Trials
Forte Trial
Expanded Access
Company
About Us
People
Leadership
Investors
Careers
Governance
Partnerships
News
Contact
Investors
Fore is backed by top investors with deep industry knowledge and a successful history of forming some of the world’s leading oncology companies.